Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Clinical Trial
. 1984;3(8):526-30.

A Multi-Centre, Double-Blind Study of Serrapeptase Versus Placebo in Post-Antrotomy Buccal Swelling

  • PMID: 6366808
Clinical Trial

A Multi-Centre, Double-Blind Study of Serrapeptase Versus Placebo in Post-Antrotomy Buccal Swelling

M Tachibana et al. Pharmatherapeutica. .

Abstract

A multi-centre, double-blind, placebo-controlled trial was carried out to investigate the clinical efficacy of the anti-inflammatory enzyme serrapeptase in a total of 174 patients who underwent Caldwell-Luc antrotomy for chronic empyema. Eighty-eight patients received 10 mg serrapeptase 3 times on the day before operation, once on the night of the operation and 3 times daily for 5 days after operation; the other 86 received placebo. Changes in buccal swelling after operation were observed as a parameter of the response to treatment. The degree of swelling in the serrapeptase-treated patients was significantly less than that in the placebo-treated patients at every point of observation after operation up to the 5th day (p less than 0.01 to p less than 0.05). Maximal swelling throughout all the post-operative points of observation was also significantly smaller in size in the serrapeptase-treated group than in the placebo-treated group. No side-effects were reported.

Similar articles

See all similar articles

Cited by 2 articles

Publication types

Feedback